TY - JOUR AU - Bing, Zhitong AU - Cheng, Zhiyuan AU - Shi, Danfeng AU - Liu, Xinkui AU - Tian, Jinhui AU - Yao, Xiaojun AU - Zhang, Jingyun AU - Wang, Yongfeng AU - Yang, Kehu PY - 2018 DA - 2018/11/06 TI - Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology JO - BMC Complementary and Alternative Medicine SP - 293 VL - 18 IS - 1 AB - Chinese traditional herbal medicine Fuzhengkangai (FZKA) formulation combination with gefitinib can overcome drug resistance and improve the prognosis of lung adenocarcinoma patients. However, the pharmacological and molecular mechanisms underlying the active ingredients, potential targets, and overcome drug resistance of the drug are still unclear. Therefore, it is necessary to explore the molecular mechanism of FZKA. SN - 1472-6882 UR - https://doi.org/10.1186/s12906-018-2347-x DO - 10.1186/s12906-018-2347-x ID - Bing2018 ER -